ArticleOPEN ACCESS

Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French innovative leukemia organization (FILO) study

Haematologica
DOI: 10.3324/haematol.2017.182352
12Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Cartron, G., Letestu, R., Dartigeas, C., Tout, M., Mahé, B., Gagez, A. L., … Leprêtre, S. (2018, July 31). Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French innovative leukemia organization (FILO) study. Haematologica. Ferrata Storti Foundation. https://doi.org/10.3324/haematol.2017.182352

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free